Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: Association with microalbuminuria and silent coronary artery disease

被引:20
作者
Nguyen, M. T. [3 ,4 ]
Cosson, E. [3 ,4 ]
Valensi, P. [3 ]
Poignard, P. [1 ]
Nitenberg, A. [1 ]
Pham, I. [1 ,2 ]
机构
[1] Hop Jean Verdier, AP HP, Serv Explorat Fonct, Bondy, France
[2] Univ Paris 13, UFR SMBH, EA 23 63, Bobigny, France
[3] Univ Paris 13, CRNH IdF, Jean Verdier Hosp, AP HP,Dept Endocrinol Diabetol Nutr, Bondy, France
[4] Univ Paris 13, UMR Inserm U557, Inra U1125, Bondy, France
关键词
Diabetes mellitus; Type; 1; diabetes; 2; Transthoracic echocardiography; Left ventricular function; Silent coronary artery disease; Silent myocardial ischaemia; Microalbuminuria; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-ISCHEMIA; DYSFUNCTION; RECOMMENDATIONS; EPIDEMIOLOGY; HYPERTENSION; MORTALITY; STENOSES; MELLITUS; EVENTS;
D O I
10.1016/j.diabet.2010.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims. - This study aimed to assess, on routine echocardiography, cardiac left ventricular (LV) disorders, their determinants and their role in the screening process of silent myocardial ischaemia (SMI) in asymptomatic diabetic patients. Methods. - A total of 586 asymptomatic diabetic patients with one or more additional cardiovascular risk factors, but no history of heart failure or myocardial infarction, prospectively underwent rest echocardiography and myocardial scintigraphy. Those with SMI (abnormal scintigraphy) were subsequently screened for angiographic coronary artery disease (CAD). Results. - LV hypertrophy, LV dilatation, systolic dysfunction and hypokinesia were found in 33.6, 8.6, 3.2 and 6.1%, respectively, of the study population. SMI was found in 156 (26.6%) patients, 55 of whom had silent CAD. On multivariate analysis, age (OR: 1.03 [1.00-1.05], P = 0.02), microalbuminuria (OR: 2.2 [1.4-3.2], P < 0.0001) and silent CAD (OR: 2.4 [1.3-4.6], P = 0.007) were predictive of LV hypertrophy. Creatinine clearance (OR: 0.97 [0.96-0.99], P = 0.002) and silent CAD (OR: 3.7 [1.3-10.0]) were associated with LV dilatation. LV systolic dysfunction was associated with microalbuminuria (OR: 3.8 [1.3-11.4], P = 0.02) and silent CAD (OR: 3.8 [1.1-12.6], P = 0.03). Hypokinesia was associated with retinopathy (OR: 2.4 [1.1-5.4], P = 0.04), microalbuminuria (OR: 2.3 [1.1-5.0], P = 0.04) and LV dilatation (OR: 3.0 [1.1-8.1], P = 0.03). In patients with SMI, the positive predictive value of LV hypertrophy associated with another echocardiographic abnormality (n = 19) for CAD was 63.2%. Conclusion. - LV hypertrophy was found in one-third of asymptomatic diabetic patients, while LV dilatation, systolic dysfunction or hypokinesia was seen in <10%. The main predictors of LV abnormalities were microalbuminuria and silent CAD. The presence of LV hypertrophy with another abnormality should raise the possibility of the presence of silent CAD. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 50 条
  • [1] RELATION OF MICROALBUMINURIA AND CORONARY ARTERY DISEASE IN NON DIABETIC PATIENTS
    Hoseini, Vida Nesar
    Taziki, Omolbanin
    ARYA ATHEROSCLEROSIS, 2008, 4 (01) : 13 - 16
  • [2] NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients
    Reinhard, Henrik
    Hansen, Peter R.
    Wiinberg, Niels
    Kjaer, Andreas
    Petersen, Claus L.
    Winther, Kaj
    Parving, Hans-Henrik
    Rossing, Peter
    Jacobsen, Peter K.
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [3] Microalbuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients
    Hoseini, Vida Nesar
    Rasouli, Mehdi
    CARDIOLOGY JOURNAL, 2009, 16 (02) : 142 - 145
  • [4] Assessment of microalbuminuria in hypertensive patients with established coronary artery disease
    Salaru, Delia L.
    Macovei, Liviu
    Statescu, Cristian
    Arsenescu-Georgescu, Catalina
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2013, 21 (04): : 407 - 414
  • [5] TO ESTIMATE THE PREVALENCE OF MICROALBUMINURIA IN NON-DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
    Rao, Bongu Srinivasa
    Rao, A. Gopal
    Naik, Sharath Babu
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (03): : 394 - 396
  • [6] Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
    Reinhard, Henrik
    Nybo, Mads
    Hansen, Peter R.
    Wiinberg, Niels
    Kjaer, Andreas
    Petersen, Claus L.
    Winther, Kaj
    Parving, Hans-Henrik
    Rasmussen, Lars M.
    Rossing, Peter
    Jacobsen, Peter K.
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [7] N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients
    Cosson, E.
    Nguyen, M. T.
    Pham, I.
    Pontet, M.
    Nitenberg, A.
    Valensi, P.
    DIABETIC MEDICINE, 2009, 26 (09) : 872 - 879
  • [8] Relationship Between Microalbuminuria and Severity of Coronary Artery Disease in Non-Diabetic Patients
    Hoseini, V. Nesar
    Taziki, O.
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2007, 1 (04) : 234 - 237
  • [9] Frequency of Asymptomatic Myocardial Ischemia in Type 2 Diabetic Patients with Microalbuminuria
    Hafsa, Fatima
    Zaman, Shahidah
    Mahmood, Asad Ullah
    Qureshi, Irshad Hussain
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (01): : 567 - 570
  • [10] Association of Coronary Artery Stenosis with Carotid Atherosclerosis in Asymptomatic Type 2 Diabetic Patients
    Irie, Yoko
    Sakamoto, Kenya
    Kubo, Fumiyo
    Okusu, Takahiro
    Katura, Takashi
    Yamamoto, Yuichi
    Umayahara, Yutaka
    Katakami, Naoto
    Kaneto, Hideaki
    Kashiyama, Toshikazu
    Ueda, Yasunori
    Kosugi, Keisuke
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (04) : 337 - 344